Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184171 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184177 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184180 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184183 |
| ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-02-09 | 2023-07-05 | 184195 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184198 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-02-09 | 2023-07-06 | 184201 |
| ACT AMLODIPINE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184204 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184207 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2023-02-16 | 2023-04-28 | 184943 |
| TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-02-16 | 2023-10-04 | 184946 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2023-02-16 | 2023-07-06 | 184949 |
| TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2023-04-27 | 2024-01-08 | 190677 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-04-27 | 2023-11-21 | 190680 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190692 |
| TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190695 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |